First-of-its-kind online program aims to prevent sexual assault among trans undergraduates
NCT ID NCT07706322
First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time
Summary
This study adapts a proven sexual assault resistance program for transgender and nonbinary undergraduates aged 18–25. The intervention, called TEA3, is a 15-hour online program that teaches skills to detect and resist sexual assault. Researchers will test whether the adapted program is feasible and acceptable, and whether it boosts participants' confidence in their ability to defend themselves.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- TEA3 intervention, a 15-hour online sexual assault resistance program adapted for transgender and nonbinary students
- What this could lead to
- If successful, this could become one of the first evidence-based sexual assault prevention interventions specifically designed for transgender and nonbinary college students.
- What could go wrong
- This is a small pilot study with only 80 participants, so results may not generalize widely. The intervention is still being adapted and tested for feasibility, not yet proven to reduce victimization.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 25 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Participants must be adults ages 18 to 25, AND * Have a gender identity that differs from their sex assigned at birth (e.g. trans or nonbinary) AND * Be an undergraduate student AND * Be available during the program times, AND * Provide the contact information for another trans or nonbinary undergraduate who they would be willing to participate in the intervention with OR express willingness to being partnered with another trans or nonbinary undergraduate at their university AND * Have access to and willingness to use the videoconferencing software Zoom for the program AND * Consent to being recorded while participating. Exclusion Criteria: * Participant is less than 18 years of age or older than 25 years of age, OR * Does not identify as a trans or nonbinary individual, OR * Is not an undergraduate student, OR * Is not available during the program times, OR * Does not provide the contact information for another trans or nonbinary undergraduate student who they would be willing to participate in the intervention with AND does not express a willingness to being partnered with another undergraduate OR * Does not have access to and or is unwilling to use the videoconferencing software Zoom, OR * Does not consent to being recorded while participating.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sexual assault and rape are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.